Abstract
Endoscopic spine surgery has advanced from a percutaneous niche technique to a mainstream platform for lumbar decompression. This original study examines the relationship between endoscopic and microscopic platforms across 7 contested domains, using an embedded cross-sectional single-round international survey to map patterns of expert agreement and divergence. Seven contested domains—learning curve, technical feasibility, patient selection, clinical and radiological outcomes, complications, cost-effectiveness, and reoperation—were each argued by a Pro-Microscopic and a Pro-Endoscopic advocate before reconciliation, then complemented by a structured single-round international survey of 105 spine surgeons from 5 world regions. The survey was designed to describe practice patterns and map the distribution of expert opinion, not to determine whether endoscopy can replace microscopy. Statements meeting a prespecified conjunctive threshold of at least 70% agreement overall and within each of 3 practice-profile strata were classified as meeting the consensus standard, with the 70% level adopted on the precedent of the CORE (Convergence of Opinion on Recommendations and Evidence) methodology. Seven statements met this standard: reduced approach-related trauma, lower surgical site infection, primacy of surgeon experience over platform, the training burden of endoscopy, standardized outcome reporting, comparable 1- to 2-year outcomes in selected stenosis, and health-system dependence of cost-effectiveness. Endoscopy-favoring distributions were modal in all 7 domains, reaching a majority for complications, outcomes, and patient selection; learning curve and cost-effectiveness remained areas of mixed opinion, and reoperation showed the widest divergence of views. Although 75.2% judged that endoscopy is ready to replace the microscope as the default platform, this fell to 38.5% (95% confidence interval, 13.9%–68.4%) among microscopically oriented surgeons and failed stratification. Endoscopy has demonstrated comparable outcomes for selected pathology and perioperative advantages in specific domains, but not durable long-term superiority. The evidence supports coexistence rather than replacement, with platform selection matched to pathology, patient phenotype, endoscopic platform, and surgeon expertise. The survey illustrates where expert practice patterns align with, diverge from, or run ahead of published comparative evidence.
Keywords: Endoscopic spine surgery, Microscopic decompression, Lumbar spinal stenosis, Unilateral biportal endoscopy, Minimally invasive spine surgery, Expert consensus
INTRODUCTION
Lumbar decompression for degenerative spinal stenosis is among the most frequently performed spinal operations worldwide, and the platform used to perform it has changed more in the past decade than in the preceding 30 years [1]. Microsurgical decompression, refined from the interlaminar microdiscectomy described by Yasargil and Caspar [2,3], has been the reference standard for a generation, and its evidence base—long-term cohorts, randomized trials, and registry data—remains the deepest in the field. Over the same period, endoscopic spine surgery (ESS) has progressed from percutaneous nucleotomy through the transforaminal corridor formalized by Kambin to a mature family of techniques encompassing uniportal full-endoscopic interlaminar decompression, uniportal lateral recess and foraminal decompression, and unilateral biportal endoscopy (UBE) [4,5]. The technical envelope of ESS now includes central canal stenosis, multilevel disease, and osseous decompression that were considered inaccessible a decade ago [6]. This expansion has generated a specific and increasingly urgent question: is endoscopy ready to replace the microscope? The question is usually posed as a binary contest, and it is frequently answered as one. Advocates point to meta-analytic evidence of comparable outcomes in disability and pain scores with consistent advantages in operative time, length of stay, and perioperative morbidity [7]. Critics answer that structural preservation has not yet been shown to translate into durable functional superiority, and that the learning curve, cost profile, and long-term revision data remain unsettled. The framing itself deserves scrutiny. “Replacement” imposes an asymmetric standard, requiring that ESS exceed microscopic surgery in efficacy across the full spectrum of decompressive indications while delivering equal or lower complication rates. That standard was recently applied to lumbar discectomy, reaching an explicit “not yet” verdict [8]; the present study extends that framework to decompression, where the technical envelope is broader and the burden of proof is correspondingly higher. The opposing position has been advanced most forcefully by Lewandrowski et al. [9], who characterize ESS as a disruptive technology constrained by reimbursement and training rather than by clinical limitation. Rather than adjudicate this question from a single editorial voice, we structure it as a formal debate complemented by practice-pattern mapping. Seven contested domains are each argued by an explicit Pro-Microscopic and an explicit Pro-Endoscopic advocate before reconciliation, and the domain-level positions are then contextualized against a structured single-round international survey. Our aim is not to declare a winner but to identify precisely where the literature is relatively consistent, where it is context-dependent, where expert opinion converges or diverges, and where the evidence remains open. The survey was designed to describe international practice patterns and map the distribution of expert opinion—not to establish formal consensus or to determine whether endoscopy can replace microscopy.
MATERIALS AND METHODS
1. Study Design
This original article combines a debate-style structured evidence review with an embedded cross-sectional single-round international expert survey. It is not a systematic review, does not follow PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) reporting, was not designed as a formal consensus study, and involved no quantitative pooling or summary effect estimation. The adversarial format was selected because the contested questions in this field concern the interpretation and sufficiency of existing evidence rather than its absence. The survey component was designed to describe international practice patterns and map the distribution of expert opinion across practice-profile strata, not to establish formal consensus or to determine whether endoscopy can replace microscopy. Because the survey constitutes original primary data collected for this study, the manuscript is submitted as an original article. The overall study design is summarized in Fig. 1.
Fig. 1.

Study design. Component 1 (left): 7 prespecified contested domains were argued by independent Pro-Endoscopic and Pro-Microscopic advocates, followed by draft exchange, one revision round, and reconciliation (Sections 2–8). Component 2 (right): a single-round international survey (n=105) that was confidential at the point of collection because optional item E4 asked respondents how they wished to be acknowledged; the E4 field was exported to a separate file held only by the corresponding authors and deleted from the response record before the analytic dataset was created, so that the analytic dataset contains no names, institutions, email addresses, or E4 responses. Statements were classified against a prespecified conjunctive consensus standard (≥70% agreement overall and within each practice-profile stratum). The 2 components are integrated in Section 9. RCT, randomized controlled trial; CORE, Convergence of Opinion on Recommendations and Evidence; CI, confidence interval.
2. Debate Structure and Advocacy Drafting
Seven contested domains were prespecified, preceded by a noncontested historical synthesis: learning curve and training; technical feasibility and surgical nuances; patient selection and indications; clinical and radiological outcomes; complication profile and management; cost-effectiveness and economic analysis; and reoperation and revision rates. For each contested domain (Sections 2–8), 2 independent advocacy positions were drafted by separate coauthors: a Pro-Endoscopic position and a Pro-Microscopic position. Each advocate was instructed to construct the strongest available case for their assigned platform, grounded in the best available evidence for that domain, rather than to produce a balanced description. Advocacy drafts were prepared without access to the opposing draft in the first round, then exchanged and revised once so that each position engaged with the strongest counterargument.
1) Literature search
Each advocate independently searched PubMed/MEDLINE and Embase, unrestricted by date but prioritizing publications from 2015 onward. Search strings paired platform descriptors (“full-endoscopic,” “biportal endoscopy,” “UBE,” “microsurgical decompression,” “microscopic laminectomy,” “tubular decompression,” “unilateral laminotomy”) with pathology and outcome terms (“lumbar spinal stenosis,” “decompression,” “outcomes,” “complications,” “cost-effectiveness”). Conflicting evidence was resolved hierarchically: randomized controlled trials (RCTs), prospective comparative studies, large registry or database analyses, and systematic reviews with meta-analyses, in that order. Selective emphasis is inherent to the adversarial format; this was tempered by requiring each position to engage the strongest counterargument after draft exchange, and by reconciling both positions against survey data in the final sections.
2) Microscopic comparators
“Microscopic decompression” herein encompasses conventional or subtotal laminectomy, microsurgical laminotomy, and tubular microscopic decompression via dilator-retractor systems —techniques that differ in soft-tissue disruption, facet preservation, and paraspinal muscle devitalization. Where evidence permits, cited studies specify the comparator used; where we refer to “microscopy” in the abstract, we mean this heterogeneous family as conventionally represented in the literature. That “microscopy” is not a uniform comparator is acknowledged throughout and examined in Section 9.5, alongside endoscopic platform heterogeneity.
3. Structured International Expert Survey
A single-round electronic survey was distributed July 1–31, 2026, to international spine surgeons with lumbar decompression experience, recruited through specialty societies, editorial networks, and professional contacts. The survey was neither a guideline process nor a consensus exercise. Its purpose was to map agreement patterns, persistent divergence, and decision variables beyond comparative literature.
1) Respondent identification and data handling
The survey was confidential rather than anonymous at the point of collection, because optional item E4 asked respondents how they wished to be acknowledged (“Name me,” “Institution only,” or “Anonymous aggregate only”). To keep identification preferences separate from the analysis, the E4 field was exported to a separate file held only by the corresponding authors (LMQ, SKC, SMP) and was deleted from the response record before the analytic dataset was created and before any stratification or analysis was performed. The analytic dataset therefore contains no names, institutions, email addresses, or E4 responses; each record carries only a sequential study number (Supplementary Material 1). The 3 respondents who selected “Name me” or “Institution only” had their identification data used solely for acknowledgment purposes; these data were never merged back with their responses and were not used in any stratified or free-text analysis. Free-text quotations are attributed only by world region, years in practice, and practice profile.
2) Ethics statement
The survey collected the professional opinions of surgeons only; no patient data were collected. Participation was voluntary and uncompensated, and submission of the completed questionnaire was considered consent to participate. This study was considered as falling outside of the scope of the Swiss legislation regulating research on human subjects, so that the need for local ethics committee approval was waived (Cantonal Commission for Research Ethics of Geneva CCER-Req-2026-01571).
The instrument comprised 5 sections: (A) demographics and practice profile; (B) domain-level judgments for the 7 contested areas; (C and D) candidate statements on Likert scales; and (E) direct assessment of the replacement threshold with nomination of most influential missing evidence. The blank instrument is provided as Supplementary Material 2. In Section B, the response options were worded in the instrument as “Resolved favoring endoscopy,” “Resolved favoring microscopy,” “Resolved – equivalent,” “Context-dependent,” and “Genuinely Unresolved.” Because a single-round survey cannot establish that any domain is resolved, these options are reported herein with neutral descriptors (favors endoscopy, favors microscopy, comparable, context-dependent, and unresolved) and are interpreted only as distributions of opinion. Statements in Sections C and D are reproduced in Tables 1 and 2 as worded in the instrument, and agreement was defined as “Agree” or “Strongly agree” on the 5-point scale.
Table 1.
Statements meeting the prespecified consensus standard (≥70% agreement overall and within each practice-profile stratum), with agreement by stratum and exact 95% confidence intervals
| Statement | Overall (n = 105) | Microscopic (n = 13) | Balanced (n = 18) | Endoscopic (n = 74) |
|---|---|---|---|---|
| C4. Endoscopic decompression is associated with lower surgical site infection rates | 95.2% (89.2–98.4) | 84.6% (54.6–98.1) | 88.9% (65.3–98.6) | 98.6% (92.7–100.0) |
| C1. Endoscopic decompression produces less approach-related soft-tissue trauma | 93.3% (86.7–97.3) | 84.6% (54.6–98.1) | 83.3% (58.6–96.4) | 97.3% (90.6–99.7) |
| C10. Surgeon experience and case selection influence complication rate more than the platform itself | 93.3% (86.7–97.3) | 92.3% (64.0–99.8) | 94.4% (72.7–99.9) | 93.2% (84.9–97.8) |
| C5. The endoscopic learning curve is steeper and requires structured training to traverse safely | 90.5% (83.2–95.3) | 84.6% (54.6–98.1) | 94.4% (72.7–99.9) | 90.5% (81.5–96.1) |
| C8. Decompression adequacy and complications should be reported with standardized definitions | 88.6% (80.9–94.0) | 100.0% (75.3–100.0) | 94.4% (72.7–99.9) | 85.1% (75.0–92.3) |
| C2. For selected lumbar spinal stenosis, endoscopic and microscopic decompression achieve equivalent 1- to 2-year functional outcomes* | 78.1% (69.0–85.6) | 84.6% (54.6–98.1) | 83.3% (58.6–96.4) | 75.7% (64.3–84.9) |
| C9. Cost-effectiveness is health-system-dependent rather than intrinsic to the technique | 76.2% (66.9–84.0) | 100.0% (75.3–100.0) | 72.2% (46.5–90.3) | 73.0% (61.4–82.6) |
Values are presented as % agreement (Agree or Strongly agree) with exact Clopper-Pearson 95% confidence intervals.
Statements are reproduced as worded in the survey instrument (Supplementary Material 2).
“Equivalent” is the instrument wording, used in its colloquial sense; it is interpreted herein as comparable outcomes, not formal statistical equivalence. “Selected” denotes 1- to 2-level central or lateral recess stenosis without instability.
Table 2.
Statements not meeting the prespecified consensus standard (mixed opinion or persistent divergence), with agreement by practice-profile stratum and exact 95% confidence intervals
| Statement | Overall (n = 105) | Microscopic (n = 13) | Balanced (n = 18) | Endoscopic (n = 74) |
|---|---|---|---|---|
| C3. Endoscopic decompression reduces length of hospital stay | 91.4% (84.4–96.0) | 61.5% (31.6–86.1)† | 100.0% (81.5–100.0) | 94.6% (86.7–98.5) |
| D6. Endoscopic decompression should be a required fellowship competency | 79.0% (70.0–86.4) | 61.5% (31.6–86.1)† | 66.7% (41.0–86.7)† | 85.1% (75.0–92.3) |
| D1. Endoscopy should now be first-line for lateral recess and foraminal stenosis | 75.2% (65.9–83.1) | 53.8% (25.1–80.8)† | 55.6% (30.8–78.5)† | 83.8% (73.4–91.3) |
| D5. Endoscopy is ready to replace the microscope as the default platform | 75.2% (65.9–83.1) | 38.5% (13.9–68.4)† | 55.6% (30.8–78.5)† | 86.5% (76.5–93.3) |
| D2. Endoscopy’s biological advantages will translate into lower long-term adjacent segment degeneration and reoperation | 69.5% (59.8–78.1)† | 46.2% (19.2–74.9)† | 61.1% (35.7–82.7)† | 75.7% (64.3–84.9) |
| C7. High-quality long-term (≥ 5 years) comparative data are currently insufficient | 68.6% (58.8–77.3)† | 76.9% (46.2–95.0) | 66.7% (41.0–86.7)† | 67.6% (55.7–78.0)† |
| D3. Endoscopy is appropriate as a default for severe multilevel central stenosis in the elderly | 64.8% (54.8–73.8)† | 23.1% (5.0–53.8)† | 33.3% (13.3–59.0)† | 79.7% (68.8–88.2) |
| D7. Reimbursement, not clinical limitation, is the principal barrier to adoption | 64.8% (54.8–73.8)† | 61.5% (31.6–86.1)† | 50.0% (26.0–74.0)† | 68.9% (57.1–79.2)† |
| C6. Endoscopic decompression outcomes differ by approach (uniportal interlaminar, biportal, uniportal foraminal–lateral recess) | 36.2% (27.0–46.1)† | 46.2% (19.2–74.9)† | 44.4% (21.5–69.2)† | 32.4% (22.0–44.3)† |
| D4. Uniportal decompression carries a meaningful risk of inadequate central canal decompression | 20.0% (12.8–28.9)† | 15.4% (1.9–45.4)† | 27.8% (9.7–53.5)† | 18.9% (10.7–29.7)† |
Values are % agreement (Agree or Strongly agree) with exact Clopper-Pearson 95% confidence intervals.
Statements are reproduced as worded in the survey instrument (Supplementary Material 2); C6 is discussed in Section 9.5.
Values fall below the 70% requirement.
3) Consensus standard and terminology
A conjunctive threshold of ≥70% agreement overall and within each practice-profile stratum (microscopic, balanced, endoscopic) was prespecified. The 70% level follows the precedent of the Convergence of Opinion on Recommendations and Evidence (CORE) methodology described by Schoenberg et al. [10], in which, in a post hoc analysis of a multiround modified Delphi process embedded in guideline development, requiring 70% agreement yielded recommendations whose direction was 98.2% concordant with those of Institute of Medicine standards–compliant guidelines. CORE is a multistep guideline-panel methodology rather than a single-round survey; it is therefore cited as precedent for the choice of threshold, not as validation of the present design. Given our single-round design, statements meeting this threshold are described as “meeting the prespecified consensus standard.” Results below threshold are termed “mixed opinion” or “persistent divergence,” and full distributions are presented as opinion gradients.
4) Statistical analysis
Proportions carry exact 95% Clopper-Pearson confidence intervals, reported in the text and in Tables 1–3, including for the microscopic stratum. No formal hypothesis testing was performed; phrases such as “tracked reimbursement environment” describe observed patterns rather than tested associations. The microscopic stratum (n=13) yields wide intervals requiring cautious interpretation. Survey reporting follows the CROSS (Consensus-Based Checklist for Reporting of Survey Studies) [11] (Supplementary Material 3).
Table 3.
Domain-level distribution of opinion (n=105), with exact 95% confidence intervals and descriptive summary
| Domain | Favors endoscopy | Comparable | Context-dependent | Unresolved | Favors microscopy | Favors endoscopy, microscopic stratum (n = 13) | Descriptive summary |
|---|---|---|---|---|---|---|---|
| Learning curve & training | 51 (48.6) (38.7–58.5) | 13 (12.4) (6.8–20.2) | 8 (7.6) (3.3–14.5) | 1 (1.0) (0.0–5.2) | 32 (30.5) (21.9–40.2) | 5/13 (38.5) (13.9–68.4) | Mixed opinion; modal endoscopy-favoring |
| Technical feasibility | 52 (49.5) (39.6–59.5) | 31 (29.5) (21.0–39.2) | 6 (5.7) (2.1–12.0) | 1 (1.0) (0.0–5.2) | 15 (14.3) (8.2–22.5) | 3/13 (23.1) (5.0–53.8) | Modal endoscopy-favoring; context-dependent on pathology and platform |
| Patient selection | 56 (53.3) (43.3–63.1) | 28 (26.7) (18.5–36.2) | 16 (15.2) (9.0–23.6) | 2 (1.9) (0.2–6.7) | 3 (2.9) (0.6–8.1) | 2/13 (15.4) (1.9–45.4) | Majority favoring endoscopy for selected phenotypes |
| Clinical & radiological outcomes | 57 (54.3) (44.3–64.0) | 31 (29.5) (21.0–39.2) | 9 (8.6) (4.0–15.6) | 2 (1.9) (0.2–6.7) | 6 (5.7) (2.1–12.0) | 4/13 (30.8) (9.1–61.4) | Majority favoring endoscopy; long-term data insufficient |
| Complications profile | 61 (58.1) (48.1–67.7) | 26 (24.8) (16.9–34.1) | 7 (6.7) (2.7–13.3) | 3 (2.9) (0.6–8.1) | 8 (7.6) (3.3–14.5) | 4/13 (30.8) (9.1–61.4) | Majority favoring endoscopy |
| Cost-effectiveness | 51 (48.6) (38.7–58.5) | 12 (11.4) (6.0–19.1) | 7 (6.7) (2.7–13.3) | 6 (5.7) (2.1–12.0) | 29 (27.6) (19.3–37.2) | 3/13 (23.1) (5.0–53.8) | Mixed opinion; health-system dependent |
| Reoperation & revision | 42 (40.0) (30.6–50.0) | 27 (25.7) (17.7–35.2) | 12 (11.4) (6.0–19.1) | 3 (2.9) (0.6–8.1) | 21 (20.0) (12.8–28.9) | 2/13 (15.4) (1.9–45.4) | Widest divergence of views |
Values are presented as number (%) with exact Clopper-Pearson 95% confidence intervals in parentheses.
Response options are reported with neutral descriptors (the original instrument wording is given in Materials and Methods). Descriptive summaries match those used in the Reconciliation sections (Sections 2–8); they describe the distribution of respondent opinion and are not evidence of comparative effectiveness.
SECTION 1. HISTORICAL PERSPECTIVE AND EVOLUTION OF VISUALIZATION
Whether endoscopy is ready to replace the microscope is typically framed as a binary question; the historical record suggests otherwise. Yasargil and Caspar [2,3] described microsurgical interlaminar discectomy in 1977, yet percutaneous nucleotomy had already been performed by Hijikata in 1973, and Kambin formalized the safe transforaminal triangle during the 1980s [4,5,12]. The 2 platforms emerged in parallel, not in sequence; the recent rise of ESS reflects cumulative optical and instrumental advances rather than sudden paradigm shift [12]. UBE developed as an independent lineage with arthroscopic roots—De Antoni’s 1996 description, Soliman’s irrigation discectomy, Eum and Son’s refined form [12,13]—distinct from the uniportal tradition. Yeung’s water-medium environment differs fundamentally from microscopic dissection in air, with distinct visualization, hemostasis, and tissue plane properties [5].
This history frames the present question. “Replacement” imposes an asymmetric standard: unmet for decompression, met but not exceeded for discectomy [8]. The disruptive technology argument [9] holds for foraminal stenosis and contained herniation, yet overreaches across the full decompressive spectrum. Sections 2–8 examine 7 contested domains as structured debate, each argued by explicit Pro-Microscopic and Pro-Endoscopic advocates before reconciliation.
SECTION 2. LEARNING CURVE AND TRAINING
1. Pro-Microscopic Position
The Pro-Endoscopic position frames the learning curve as a transient, front-loaded investment. This is rhetorically elegant yet understates both its magnitude and the patient burden it entails. Transition from open to microsurgical decompression leverages existing tactile skills within the same air medium, preserving binocular depth perception and bimanual dexterity. Endoscopic surgery—uniportal or biportal—demands a distinct motor repertoire in water: stereopsis is lost, tactile feedback attenuated, 3-dimensional anatomy reconstructed from 2-dimensional fields [14]. These are not incremental extensions but a separate technical discipline. The quantitative evidence undermines the investment narrative. In an LC-CUSUM (Learning Curve-Cumulative Summation) analysis of a surgeon proficient in microscopic laminectomy but naive to biportal endoscopy, competency was not achieved until the 58th case; mean operative time was 105.3±39.7 minutes in the first 30 procedures versus 62.4±19.9 minutes in the second 30, with the 10% overall complication rate concentrated before competency [15]. Nearly 60 consecutive patients thus bore elevated technical risk.
The purported 20-case plateau for simple biportal decompression reflects operative-time convergence in selected single-level stenosis, not complication-weighted proficiency or complex disease [16]. Most published learning-curve data derive from high-volume Asian and European centers; generalizability to surgeons performing fewer than 5 monthly decompressions remains unproven [17]. No validated, complication-weighted proficiency benchmark exists beyond simple decompression. Without structured dissemination pathways, the learning curve remains a structural barrier, not a transient inconvenience.
2. Pro-Endoscopic Position
Critics have long cited the learning curve as the principal barrier to endoscopic adoption, with historical literature reporting case-volume thresholds from 20 to over 60 procedures depending on technique [18]. This apprehension reflects a methodological flaw: prior work has relied on raw operative-time plateaus rather than complication-weighted endpoints, conflating technical speed with clinical safety [19]. Moreover, early data derive predominantly from single-surgeon series in ultra-high-volume Asian and European centers, limiting generalizability to mid-career adopters in standard settings [17].
Properly managed, the endoscopic learning curve is a transient, front-loaded investment yielding predictable clinical safety—not an inherent platform disadvantage. Contemporary data demonstrate procedure-specific, modular trajectories: Peng et al. [16] showed that simple UBE decompression proficiency plateaus near 20 cases, with complex competency acquired incrementally thereafter. Real-world data refute that early-phase patients receive substandard care; Scherman et al. [20] found good-to-excellent outcomes across a surgeon’s initial 105 cases, indicating that strategic case selection mitigates inexperience. The largest randomized comparison of endoscopic and open discectomy—a formal noninferiority trial with a prespecified margin, conducted by trained surgeons—demonstrated noninferiority of full-endoscopic discectomy for sciatica-related disability [21], although this discectomy trial provides only indirect evidence for decompression and cannot characterize the learning-curve phase itself.
The debate must shift from arbitrary case-volume thresholds to structured, complication-weighted training frameworks. Proficiency is meaningfully defined not by operative time alone, but by convergence of time, complication profiles, and patient-reported outcomes with the surgeon’s microsurgical baseline. Training infrastructure, rather than baseline case volume alone, appears to be an important determinant of safe dissemination, although this relationship has not been tested directly.
3. Reconciliation & Equipoise Status
Distribution: mixed opinion; modal endoscopy-favoring
Both advocates agree on the underlying fact; they diverge on its implications. Endoscopic proficiency is front-loaded and technique-specific: the 20-case plateau for simple biportal decompression is achievable, yet complex constructs demand substantially more, with no validated complication-weighted benchmark for either platform. Microscopic skill is not curve-free—it is assumed by default through conventional training, an assumption increasingly tenuous as open decompression volumes decline.
Whether this transition burden should constrain adoption is the contested question. It weighs heaviest on mid-career, standard-volume adopters lacking arthroscopic foundations; lightest on trainees entering endoscopy-capable programs. Published plateaus, overwhelmingly from high-volume centers, describe the second case yet are routinely generalized to the first. Safe dissemination is likely to depend substantially on structured training infrastructure—cadaveric work, mentorship, stepwise case selection—not unsupervised volume accumulation.
The survey (Section 9.2) shows mixed opinion with modal endoscopy-favoring distribution: 48.6% (95% confidence interval [CI], 38.7%–58.5%) favored endoscopy versus 30.5% (95% CI, 21.9%–40.2%) microscopy, with the split tracking practice profile. Notably, 90.5% (95% CI, 83.2%–95.3%) of the panel—including most who consider endoscopy ready to replace the microscope—affirmed that its learning curve is steeper and requires structured training to traverse safely.
SECTION 3. TECHNICAL FEASIBILITY AND SURGICAL NUANCES
1. Pro-Microscopic Position
The endoscope’s coaxial architecture—uniportal or biportal—constrains instrument angulation and bimanual dexterity in water, where tactile appreciation of bone density is attenuated and stereoscopic depth perception absent [22]. These constraints become liabilities once pathology exceeds focal single-level disease. Extensive osteophytic decompression, multilevel stenosis, and trefoil morphology require iterative repositioning and repeated fluoroscopy, prolonging operative time relative to the microscope’s continuous, unrestricted bimanual exposure [22,23].
In revision settings with dense epidural adhesions or aberrant anatomy, the microscope retains decisive advantages. Stereoscopic visualization and direct tactile appreciation of scarred planes permit safer dissection around adherent neural elements; hydrostatic irrigation obscures boundaries and degrades tissue consistency discrimination [23]. The open field facilitates immediate hemostasis, robust dural repair, and rapid extension to fusion instrumentation when unexpected instability arises—capabilities a narrow endoscopic channel cannot replicate without conversion [24].
The microscope remains the pragmatic default for complex multilevel stenosis, extensive bony work, and revision surgery. Platform selection should be pathology-driven: endoscopy excels in focal foraminal or single-level central disease; microscopy is indispensable when structural complexity or navigation through scarred epidural planes is required.
2. Pro-Endoscopic Position
Endoscopic decompression is not a constrained imitation of microsurgery but, within appropriate corridors, a technically advantageous approach within an expanding domain. The continuous-irrigation, high-definition field delivers magnification and illumination exceeding the operating microscope in deep corridors, where microscopic visualization degrades from light attenuation and line-of-sight restriction [14]. In foraminal and lateral-recess pathology, the endoscope follows the exiting nerve root’s natural trajectory, enabling direct decompression without facet resection or pars compromise frequently demanded by microscopic approaches [6]. This is a meaningful anatomical advantage: the endoscope accesses pathology the microscope reaches only by sacrificing stabilizing bone.
Far from a constrained niche, endoscopy’s technical envelope now encompasses most degenerative decompressive indications and continues to widen. UBE restores full bimanual instrument freedom in water, eliminating the single-channel constraint critics cite while preserving the minimally invasive corridor [25]. Large-channel systems, high-speed endoscopic drills, and ultrasonic bone instruments have rendered central canal stenosis, multilevel decompression, and bony work—once considered beyond reach—routine [6]. A randomized trial of full-endoscopic laminotomy versus subtotal laminectomy reported comparable decompression with significantly greater facet-joint preservation—a radiological finding that may lower the risk of iatrogenic instability, although that clinical benefit has not been directly demonstrated [26]. Technical feasibility is increasingly well supported across a widening range of indications, and expansion continues.
3. Reconciliation & Equipoise Status
Distribution: modal endoscopy-favoring; context-dependent on pathology and platform type
The positions are less opposed than they appear—they address different operative problems. For foraminal stenosis, lateral recess disease, and 1- to 2-level central stenosis, the endoscopic advantage in decompression geometry is radiographically demonstrated: the endoscope follows the root trajectory, achieving adequate canal and recess expansion with less stabilizing bone removal. For severe multilevel stenosis, extensive osteophytosis, trefoil morphology, and revision through dense adhesions, the microscope’s unrestricted bimanual field, stereopsis, and capacity for immediate escalation to hemostasis, dural repair, or instrumentation remain decisive.
Both advocates concede that the limiting factor is conversion threshold, not corridor. Endoscopic practice without a rehearsed pathway to open conversion introduces risk that the platform itself does not carry. The hybrid trajectory—large-channel systems, ultrasonic bone instruments, biportal bimanual work, navigation—is narrowing this gap, yet each adjunct requires validation on decompression-specific endpoints, not feasibility alone.
This demands particular attention to platform specificity. The Pro-Microscopic argument regarding constrained instrument angulation and absent bimanual freedom applies fully to singlechannel uniportal systems, only partially to biportal constructs that restore bimanual freedom by design; conversely, the Pro-Endoscopic case for osseous work in severe stenosis rests disproportionately on biportal capability. Read as claims about “endoscopy” generically, both overstate; read platform-specifically, both hold within their scope. This heterogeneity is examined in Section 9.5.
The survey (Section 9.2) shows modal endoscopy-favoring distribution: 49.5% (95% CI, 39.6%–59.5%) favored endoscopy, 29.5% (95% CI, 21.0%–39.2%) comparable, 14.3% (95% CI, 8.2%–22.5%) microscopy—yet respondents divided evenly on whether outcomes differ meaningfully across uniportal interlaminar, biportal, and uniportal foraminal approaches (36.2% agree, 30.5% disagree), the least settled question in the survey and the subject of Section 9.5.
SECTION 4. PATIENT SELECTION AND INDICATIONS: DEFINING THE CLINICAL HIERARCHY
1. Pro-Microscopic Position
Expanding endoscopic indications should not obscure boundaries where microscopy remains the safer default. Endoscopy suits focal disc herniation and discrete single-level stenosis; its extrapolation to severe multilevel central stenosis, spondylolisthesis requiring fusion, and revision with dense epidural scarring remains premature [27]. A propensity-matched analysis of 2,618 patients found endoscopic discectomy carried higher 2-year repeat decompression rates than microdiscectomy (8.3% vs. 4.3%) and greater postlaminectomy syndrome incidence, undermining claims of durable advantage [28]. This evidence derives from lumbar discectomy literature and should be treated as indirect support for stenosis decompression.
Where instability coexists with stenosis, evidence favors microscopic reconstruction. A network meta-analysis found minimally invasive transforaminal lumbar interbody fusion (TLIF) achieved superior disability improvement and fusion rates compared with endoscopic TLIF [29]. Endoscopic fusion should be reserved for selected low-grade slips, not substituted for microscopic instrumentation in unstable or multilevel pathology.
Modifiers also temper enthusiasm. Endoscopy is technically feasible in obese patients, yet pooled data confirm prolonged operative times and higher recurrence risk, requiring stratification rather than indiscriminate adoption [30]. During the initial learning curve, calcified herniation, central canal stenosis, and concurrent degenerative stenosis independently predict clinical failure—these subtypes are more safely managed microscopically until endoscopic proficiency is established [20]. Platform selection should follow a bifurcated hierarchy: endoscopy for discrete, stable, focal disease; microscopy for multilevel degeneration, overt instability, and complex revision.
2. Pro-Endoscopic Position
Endoscopic indications have expanded well beyond the contained disc herniation to which the technique was once confined, with evidence supporting rather than cautioning against this widening. For 1- to 2-level stenosis—the most common decompressive scenario—endoscopy is now the rational first choice, delivering comparable functional outcomes with markedly faster recovery [7]. Robust data now support endoscopic decompression in historically unfavorable populations: a systematic review and meta-analysis by Liawrungrueang et al. [30] demonstrated safety and efficacy in obese patients, where avoiding a long open corridor through thick soft tissue precisely confers the minimally invasive approach’s greatest relative benefit.
Patient selection should be framed by demonstrated capability, not inherited caution. Endoscopy uniquely preserves the option value of the untouched corridor: without traversing or scarring midline posterior structures, anatomy remains intact for future intervention, and the revision setting itself benefits from access through virgin tissue planes [31]. For elderly patients with degenerative stenosis and medical comorbidity, the reduced physiological burden—minimal blood loss, frequent avoidance of general anesthesia, rapid mobilization—directly addresses the population at highest perioperative risk under open microsurgery. Frailty-stratified comparative data confirm superior functional recovery and muscle preservation with biportal endoscopic decompression in precisely this cohort [32]. The candidate pool is broad and growing; restricting it to the simplest cases understates a decade of accumulated evidence.
3. Reconciliation & Equipoise Status
Distribution: majority favoring endoscopy for selected phenotypes, with explicit boundaries
This domain shows the closest convergence between positions—both ultimately argue for stratification, not a single default. For 1- to 2-level central or lateral recess stenosis, endoscopy is increasingly used as a first-line option, though expert opinion on this as default remains divided (D1: 75.2% overall, 53.8% microscopic stratum, 55.6% balanced stratum). It is also increasingly used for primary foraminal pathology, obese patients where a long open corridor through thick soft tissue carries its own morbidity, and frail elderly patients where minimizing physiological burden is paramount. Microscopy remains appropriate for severe multilevel disease, overt instability or spondylolisthesis requiring fusion, calcified or heavily osseous pathology, and revision through dense epidural scarring.
Two modifiers cut across this hierarchy. First, learning-curve phase: calcified herniation, central canal stenosis, and concurrent degenerative stenosis predict clinical failure during early endoscopic experience, so the boundary moves with individual surgeon proficiency. Second, the untouched-corridor argument is bidirectional—endoscopy preserves virgin planes for future intervention, yet the same conservatism raises decompression adequacy questions in severe stenosis, addressed in Section 5.
The survey (Section 9.2) shows majority favoring endoscopy: 53.3% (95% CI, 43.3%–63.1%), with 26.7% (95% CI, 18.5%–36.2%) comparable and fewer than 3% microscopy. “Selected” herein denotes 1- to 2-level central or lateral recess stenosis without instability; divergent respondent interpretation is acknowledged as a limitation. Agreement narrows sharply at the boundary: endoscopy as default for severe multilevel central stenosis in the elderly fell to 64.8% overall (95% CI, 54.8%–73.8%) and to 23.1% (3 of 13; 95% CI, 5.0%–53.8%) in the microscopic stratum.
SECTION 5. CLINICAL AND RADIOLOGICAL OUTCOMES: REDEFINING SUCCESS METRICS
1. Pro-Microscopic Position
Endoscopic surgery demonstrably reduces perioperative morbidity and produces smaller radiological defects. Whether structural preservation translates into durable long-term functional superiority remains empirically vacant. UBE achieved greater radiological dural sac expansion than tubular microscopic decompression, yet clinical outcomes at 3 and 12 months were indistinguishable—superior imaging metrics do not automatically confer clinical advantage [33]. Prospective comparison showed multifidus fatty infiltration increased significantly 1 year after both conventional microdiscectomy and minimally invasive decompression, with no between-group difference, undercutting the claim that muscle preservation alone improves biological recovery [34].
In severe central canal stenosis, the endoscope’s smaller dural sac expansion and more conservative bony removal raise legitimate underdecompression concern. Postoperative cauda equina clumping occurred in 40.8% after biportal endoscopic decompression for severe stenosis, correlating with worse intermediate-term pain and disability [35]. This finding derives specifically from biportal endoscopy and should not be generalized to uniportal approaches without further evidence.
Pooled margins of comparable outcomes in meta-analysis frequently fall below the minimal clinically important difference—similar Oswestry Disability Index (ODI) and visual analog scale scores represent concession, not victory. The most recent synthesis confirmed no significant difference at 2 years while explicitly calling for prospective long-term studies to settle adjacent segment degeneration (ASD) and iatrogenic instability questions [7]. Until those data mature, the microscopic standard—judged by confirmed decompression extent and functional recovery, not structural preservation—remains the more predictable benchmark for durable outcomes.
2. Pro-Endoscopic Position
On clinical outcomes defining decompression success, endoscopy matches the microscopic standard while delivering superior perioperative and structural results. A randomized trial of full-endoscopic interlaminar versus microsurgical decompression for central stenosis reported comparable clinical results, with leg-pain resolution in the great majority and significantly fewer complications and revisions in the endoscopic arm [36]. Meta-analysis of 6 RCTs confirms no significant difference in disability and pain outcomes, with consistent advantages in operative time and length of stay [37]. Biportal endoscopic decompression shows the same pattern against microscopic laminectomy: comparable ODI and leg-pain outcomes with reduced perioperative morbidity [38,39].
Postdecompression imaging demonstrates that endoscopic and biportal techniques achieve canal and lateral-recess expansion comparable to microsurgical laminotomy, while removing markedly less bone and sparing facet joints, the supraspinous-interspinous complex, and paraspinal musculature [40,41]. The unilateral-approach-for-bilateral-decompression technique preserves the contralateral lamina and facet entirely—a structural economy open midline laminectomy cannot match [42]. This preservation of the stabilizing posterior column provides a mechanistic rationale for potential long-term advantage as durable comparative data mature: decompression relieving neural compression while conserving structures preventing iatrogenic instability may prove superior, but this remains a hypothesis awaiting empirical confirmation.
3. Reconciliation & Equipoise Status
Distribution: majority favoring endoscopy; comparable outcomes with perioperative advantages, long-term data insufficient
Neither advocate disputes the central empirical finding: disability and pain outcomes are comparable at 12–24 months across randomized trials and meta-analyses, with endoscopy holding consistent advantage in operative time, blood loss, and length of stay. The dispute concerns what should count as an outcome and over what horizon.
Endoscopy demonstrably preserves more structure—facet joints, the supraspinous-interspinous complex, the ligamentum flavum, and paraspinal musculature—yet whether this economy converts into functional dividend is untested and cannot be tested with current follow-up. The counter-concern is symmetrical: more conservative bony removal in severe central stenosis raises legitimate decompression adequacy questions, anchored empirically by cauda equina clumping data from biportal endoscopy. A methodological point applies to both sides: where pooled margins of comparability fall below the minimal clinically important difference, “comparable” reflects outcome instrument sensitivity as much as true clinical comparability. Neither platform has demonstrated superiority beyond 5 years; no dataset settles ASD or iatrogenic instability.
The survey (Section 9.2) shows majority favoring endoscopy: 54.3% (95% CI, 44.3%–64.0%), with 29.5% (95% CI, 21.0%–39.2%) comparable—yet 68.6% (95% CI, 58.8%–77.3%) simultaneously judged high-quality long-term comparative data insufficient. The inadequate decompression concern marks the sharpest divergence between evidence synthesis and surveyed panel: only 20.0% (95% CI, 12.8%–28.9%) accepted it as meaningful risk, rejected within every practice-profile stratum including the microscopic. This rejection cannot be attributed to sampling bias; it is examined in Section 9.4.1 rather than treated as simple evidentiary disagreement.
SECTION 6. COMPLICATIONS PROFILE AND MANAGEMENT: SHIFTING THE RISK LANDSCAPE
1. Pro-Microscopic Position
The claim that endoscopy categorically reduces complications conflates wound-related advantage with overall safety. A pooled analysis of 2 randomized trials comparing biportal endoscopic with microscopic surgery found no significant difference in overall adverse-event rates (9.1% vs. 17.3%, p=0.133); dural tears, epidural hematoma, and nerve-root injury occurred with similar frequency in both arms [43]. Complication burden is shifted, not removed.
What is shifted are endoscopic-specific hazards that remain under-recognized. Continuous saline irrigation introduces pressure dysregulation risks—headache, neck pain, seizure—while large-volume fluid extravasation into the retroperitoneal space has been documented and is likely underreported [44]. Dural tears, though comparable in incidence, are technically difficult to repair through a narrow channel; published series emphasize successful in situ grafting, yet the true conversion rate to open repair is almost certainly higher than acknowledged, particularly during the learning curve [45].
Cohort-level meta-analysis further shows full-endoscopic discectomy carries significantly higher residual fragment risk (risk ratio [RR], 5.29) and revision surgery (RR, 1.53) than open or microscopic approaches, alongside markedly elevated transient dysesthesia [46]. This evidence derives from lumbar discectomy literature and should be treated as indirect support for stenosis decompression. Endoscopy thus trades classical wound morbidity for procedure-specific technical failures and neurologic sequelae. Until prospective registries mandate standardized reporting of irrigation-related events, thermal injury, and unplanned conversion, the net complication advantage remains unproven.
2. Pro-Endoscopic Position
The complication profile is where the Pro-Endoscopic case for decompression is strongest. A network meta-analysis of surgical interventions for degenerative lumbar spinal stenosis identified endoscopic-assisted laminotomy as associated with significantly fewer adverse events from any cause than conventional laminectomy (odds ratio, 0.27), ranking it among the safest and most effective interventions for improving physical function [47]. Randomized trials of full-endoscopic interlaminar decompression against microsurgical technique concordantly reported significantly reduced complication and revision rates in the endoscopic arm for both central and lateral recess stenosis [36,48]. For an operation performed predominantly in elderly, comorbid patients, a reduction in adverse-event burden of this magnitude would represent a clinically meaningful safety advantage, although these estimates derive from small trials and indirect network comparisons.
Crucially, the endoscopic risk profile is not merely shifted but favorably shifted. Small incision, minimal dead space, and continuous saline irrigation reduce surgical site infection, demonstrated in propensity-score–matched analysis showing significantly fewer infections after full-endoscopic spine surgery [49]. The feared complications of open laminectomy—wound infection, symptomatic epidural hematoma in large dead space, extensive paraspinal muscle devitalization—are structurally less likely endoscopically. Where critics cite technical difficulty managing intraoperative durotomy endoscopically, dedicated meta-analysis shows durotomy incidence is low and does not increase relative to microsurgery, with the majority managed without open conversion [50].
3. Reconciliation & Equipoise Status
Distribution: majority favoring endoscopy, with conditional measurement gaps
The wound-related advantage is the most consistently supported finding in this domain. Reduced dead space, minimal soft-tissue devitalization, and continuous irrigation are associated with lower surgical site infection and overall adverse-event rates in propensity-matched and network meta-analytic data—disproportionately important in the elderly, comorbid population comprising most decompression candidates.
The disagreement concerns what lies beneath this aggregate. Pooled randomized data show serious neurological events—dural tear, epidural hematoma, nerve-root injury—occur at broadly similar frequency in both arms; risk is redistributed, not eliminated. Endoscopy substitutes platform-specific hazards for classical wound complications of open surgery: irrigation-pressure effects, fluid extravasation, thermal injury, and greater difficulty repairing durotomy through a narrow channel. Both advocates agree these events are underreported; they diverge only on likely magnitude once reporting improves—an empirical question current data cannot answer.
Resolution is therefore conditional on measurement. Prospective registries with standardized definitions of decompression adequacy, irrigation parameters, thermal events, and unplanned conversion are required; 88.6% (95% CI, 80.9%–94.0%) of the expert panel endorsed this. The survey (Section 9.2) shows the strongest majority favoring endoscopy of any domain: 58.1% (95% CI, 48.1%–67.7%), with 95.2% (95% CI, 89.2%–98.4%) agreeing endoscopic decompression is associated with lower surgical site infection rates.
SECTION 7. COST-EFFECTIVENESS AND ECONOMIC ANALYSIS
1. Pro-Microscopic Position
Claims of economic parity rest on hospital-level accounting that obscures true adoption costs. Formal modeling reports a 3.9% 1-year total cost difference, yet this marginal figure masks markedly higher per-case expenditure from disposable kits, capital acquisition, and shorter instrument lifespan [51]. In cost-sensitive or high-volume settings this consumable premium is unsustainable where reimbursement does not adjust for proprietary technology.
Cost-effectiveness analyses incorporating quality-adjusted life-years (QALYs) remain absent for decompression; the sole QALY-based comparison derives from discectomy literature and cannot be extrapolated across the decompressive spectrum [52]—acknowledged herein as indirect support. Microscopy benefits from lower capital and consumable overhead, reusable instrumentation, and established supply chains amortizing efficiently across high volumes.
Large-scale database analysis further weakens the economic case: at 2 years, endoscopic lumbar decompression incurred higher total costs than open decompression, with more than double the subsequent lumbar surgery rate (16% vs. 7%), suggesting downstream revision expenditure may negate initial perioperative savings [53]. Reduced complication-related costs cited by endoscopic advocates remain theoretically sound yet empirically unquantified in decompression-specific models [51]. Without perspective-standardized cost-effectiveness trials demonstrating clear societal advantage, microscopy retains economic default status as the budget-predictable platform for routine decompressive surgery.
2. Pro-Endoscopic Position
Cost is frequently cited as the decisive barrier to endoscopic adoption, yet decompression-specific evidence shows the platforms are closely comparable, not meaningfully separated. A formal cost-analysis model comparing full-endoscopic interlaminar with conventional microsurgical decompression for lumbar spinal stenosis found a 3.9% 1-year total cost difference —endoscopic procedures carried higher consumable and equipment costs, but generated 28.1% lower complication-related costs, rendering the overall difference small, with no significant difference in clinical outcomes demonstrated [51]. A United States single-institution analysis similarly found the cost gap driven principally by advanced technology price, not clinical effectiveness differential [54]. The accurate reading is not that endoscopy is dramatically cheaper, but that it delivers comparable decompression at broadly similar cost while shifting expenditure away from complications.
The Pro-Endoscopic economic argument is thus one of trajectory, not present-day price superiority. The consumable premium—disposable instrumentation and capital amortization—falls as volumes rise, while lower complication expenditure is already demonstrable [51]. Extending analysis from index episode to downstream and societal costs (readmissions, reoperations, lost productivity) further favors endoscopy given its adverse-event and infection profile [47,49]. The sole QALY-based comparison in the wider literature, conducted in discectomy, demonstrates this broader perspective can reverse apparent hospital-level cost disadvantage [52]—acknowledged herein as indirect evidence. On current decompression-specific data the platforms are economically comparable; the trend favors endoscopy as programs mature.
3. Reconciliation & Equipoise Status
Distribution: mixed opinion, health-system dependent
Both advocates read the same datum in opposite directions—both defensible. A 3.9% 1-year total cost difference is either parity or a figure concealing a structural consumable premium, depending on which cost center bears the burden and whether the analysis is confined to the index episode.
What appears clear: the economic question is not intrinsic to platform. Where reimbursement accommodates proprietary technology and volumes amortize capital, the endoscopic premium is absorbable and complication-cost offset is realizable. Where reimbursement does not adjust and volumes are low, the same premium is prohibitive regardless of clinical performance. The principal missing evidence is identical for both: no decompression-specific cost-utility analysis with QALYs exists, and the sole QALY-based comparison derives from discectomy and cannot be extrapolated across the decompressive envelope.
Cost-effectiveness should not be decisive for either platform at present. The survey (Section 9.2) shows mixed opinion: 48.6% favoring endoscopy, 27.6% microscopy—with the split tracking reimbursement environment, not clinical experience: 65.8% (95% CI, 48.6%–80.4%) in fee-for-service settings versus 35.7% (95% CI, 18.6%–55.9%) in single-payer systems. This association was not formally tested, given the observational design. Separately, 76.2% (95% CI, 66.9%–84.0%) endorsed cost-effectiveness as health-system-dependent, not technique-intrinsic.
SECTION 8. REOPERATION AND REVISION RATES: LONG-TERM SUSTAINABILITY
1. Pro-Microscopic Position
Endoscopic claims of comparable or superior long-term durability are challenged by large-scale longitudinal data. A propensity-matched analysis of 2,618 patients found endoscopic discectomy carried significantly higher 2-year repeat decompression risk than microdiscectomy (8.3% vs. 4.3%; hazard ratio, 2.03) and greater postlaminectomy syndrome incidence [28]—discectomy-based evidence providing indirect support for decompression. A national database study similarly found endoscopic patients more than twice as likely to undergo a second lumbar procedure within 2 years [53].
These findings suggest narrower decompression through constrained channels risks residual stenosis, converting short-term minimally invasive gain into intermediate-term revision burden. Randomized trials cited by endoscopic advocates—reporting fewer revisions—are small single-center cohorts underpowered for this endpoint; the largest independent randomized trial found no significant difference in 1-year reoperation rates [21].
The mechanistic promise that facet and muscle preservation reduces late instability-driven reoperation remains empirically vacant. Durability data beyond 5 years are absent; ASD claims rest on radiological surrogates, not validated clinical outcomes. A comparative study of revision for adjacent-segment disease found percutaneous endoscopic decompression carried higher likelihood of subsequent revision than traditional open revision [55]. Without decade-long, subtype-stratified registry data, microscopy offers the more predictable durability profile.
2. Pro-Endoscopic Position
Reoperation rates after endoscopic decompression are at least comparable to microsurgical laminectomy, with randomized evidence pointing to fewer revisions. Both trials of full-endoscopic interlaminar decompression against microsurgical technique—for central and lateral recess stenosis—reported significantly reduced revision rates in the endoscopic arm [36,48]. The structural economy of unilateral-approach decompression, preserving facet joints and contralateral posterior elements, directly targets postlaminectomy instability driving substantial revision burden after open surgery [41]. This is reinforced by multicenter propensity-matched analysis: 30-day surgical revision rates were indistinguishable, yet endoscopic surgery achieved approximately fourfold lower 30-day readmission and shorter hospital stay [56].
Beyond comparable revision frequency, endoscopy may hold an underappreciated advantage when revision becomes necessary. Primary endoscopic decompression avoids midline scar and dense epidural fibrosis of open laminectomy, preserving cleaner tissue planes for subsequent intervention. Revision through full-endoscopic transforaminal or interlaminar approach accesses pathology via virgin or minimally scarred corridors—demonstrated in patients with prior posterior decompression [31]. Posterior tension band preservation also reduces likelihood that the index operation precipitates instability requiring fusion [41]. Endoscopy may thus be comparable to microsurgery in revision frequency and may offer a strategic advantage when revision is required, although comparative revision data remain limited.
3. Reconciliation & Equipoise Status
Distribution: widest divergence of views; evidence uncertain
Short-term reassurance is not disputed. Thirty-day revision rates are indistinguishable between platforms in large-scale propensity-matched analysis; readmission favors endoscopy. Beyond this horizon, the evidence becomes contradictory: randomized trials report fewer revisions with endoscopy yet are small, single-center, and underpowered for this endpoint; large administrative datasets report the opposite with greater precision but without adjustment for pathology subtype, decompression adequacy, or learning-curve phase.
The open question is mechanism, not aggregate rate. Endoscopic failure plausibly reflects incomplete decompression or residual pathology, particularly in severe central stenosis and early experience. Microscopic failure plausibly reflects late instability from greater facet and posterior-element resection. Different failure modes on different timescales—pooled revision counts cannot distinguish them. Structural preservation reducing late instability-driven reoperation provides sound rationale but remains hypothesis without confirmatory data; constrained corridors producing residual stenosis has database support without subtype adjustment.
Both advocates converge on required study design: future reporting must separate index-level recurrence, adjacent-segment disease, iatrogenic instability, and conversion to fusion, extending to 10 years with subtype stratification. The survey (Section 9.2) shows the weakest endoscopic signal and widest dispersion of any domain: 40.0% favoring endoscopy, 25.7% comparable, 20.0% favoring microscopy—a pattern consistent with substantive uncertainty among experienced panelists.
SECTION 9. EXPERT SURVEY: AGREEMENT, MIXED OPINION, AND DIVERGENCE
1. External Consensus Landscape
International expert bodies have repeatedly examined this question and consistently declined to settle it. The World Federation of Neurosurgical Societies (WFNS) Spine Committee convened 16 experienced surgeons who reviewed evidence and voted on 44 statements addressing decompressive surgery for lumbar spinal stenosis; 36 reached consensus, yet none on equivalence of microscopic and open techniques or best surgical technique overall—minimally invasive approaches were judged advantageous over open decompression for early outcomes and complication rates [57]. Subsequent WFNS recommendations on primary lumbar disc herniation reached similarly qualified conclusions without endorsing replacement [58].
Recent processes have settled procedural questions while leaving the platform question open. The Neurocore-SENSED consensus assembled 77 surgeons across 3 continents in a 3-round modified Delphi, reaching agreement on 99 of 183 items concerning patient characteristics, technical parameters, and outcome measures—but not on replacing microsurgery [59]. The international classification of endoscopic spine procedures, developed from 112 surgeons in 27 countries, addressed procedural complexity grading rather than platform replacement [60]. Personalized matching of platform to pathology, articulated across 14 international societies, is the position most consistent with current evidence [61]. A contradictory reading exists: WFNS recommendations on percutaneous techniques position percutaneous and endoscopic decompression as alternatives to microsurgery for selected indications [62]. The reconciling interpretation: consensus documents consistently support ESS as an option for defined indications without endorsing it as default platform.
The absence of WFNS consensus on technique equivalence is this literature’s most informative negative finding, reflecting real surgeon-level disagreement rather than methodological failure—and identifying the gap the present survey was designed to characterize.
2. Respondent Characteristics and Domain-Level Distribution of Opinion
1) Respondent characteristics
The survey was completed by 105 spine surgeons: 62 orthopedic (59.0%) and 43 neurosurgeons (41.0%). The panel was experienced—29 (27.6%) with more than 20 years in independent practice, 38 (36.2%) with 11–20 years, 24 (22.9%) with 5–10 years, and 14 (13.3%) with fewer than 5 years. Decompression volume was substantial: 26 (24.8%) performed more than 150 lumbar decompressions annually, 35 (33.3%) 76–150, 34 (32.4%) 25–75, and 10 (9.5%) fewer than 25.
Five world regions were represented: Asia-Pacific 40 (38.1%), Latin America 28 (26.7%), Europe 23 (21.9%), Middle East/Africa 9 (8.6%), and North America 5 (4.8%). Reimbursement environments: mixed 39 (37.1%), predominantly fee-for-service or private 38 (36.2%), single-payer or public 28 (26.7%).
Technique exposure: uniportal full-endoscopic interlaminar unilateral laminotomy for bilateral decompression (ULBD) 81 (77.1%), uniportal lateral recess or foraminal decompression 67 (63.8%), unilateral biportal endoscopic decompression 52 (49.5%); 70 (66.7%) performed more than one endoscopic platform. Practice profile was heavily endoscopy-weighted: 45 (42.9%) almost exclusively endoscopic, 29 (27.6%) predominantly endoscopic, 18 (17.1%) balanced, 12 (11.4%) predominantly microscopic, and 1 (1.0%) almost exclusively microscopic or open. This skew is a defining dataset property, not incidental limitation; all findings are interpreted accordingly. The 3 practice-profile strata used throughout are microscopic (n=13), balanced (n=18), and endoscopic (n=74).
2) Distribution of opinion by domain
Table 3 presents the domain-level distribution of opinion (n=105) with 95% confidence intervals. Endoscopy-favoring distributions were modal in all 7 domains, but the margin and the shape of dissent differed materially across them.
Three domains showed majority (>50%) favoring endoscopy: complications 58.1% (95% CI, 48.1%–67.7%), clinical and radiological outcomes 54.3% (95% CI, 44.3%–64.0%), and patient selection 53.3% (95% CI, 43.3%–63.1%)—with a further quarter in the latter 2 selecting comparable, yielding 83.8% and 80.0% respectively at endoscopic advantage or parity, and fewer than 6% favoring microscopy. Two domains showed mixed opinion with both directional categories exceeding 25%: learning curve and training (48.6% vs. 30.5%, the largest pro-microscopic minority) and cost-effectiveness (48.6% vs. 27.6%). The remaining 2 were more nuanced: technical feasibility (49.5%, with 29.5% comparable) and reoperation and revision, producing the weakest endoscopic signal (40.0%) and widest dispersion. In the microscopic stratum (n=13), endoscopy-favoring responses ranged from 15.4% (2 of 13; 95% CI, 1.9%–45.4%) for patient selection and for reoperation to 38.5% (5 of 13; 95% CI, 13.9%–68.4%) for learning curve (Table 3).
3. Statements Meeting the Prespecified Consensus Standard
Seven statements met the prespecified conjunctive consensus standard, reaching at least 70% agreement overall and at least 70% within each of the 3 practice-profile strata. These are the items whose agreement does not depend on the endoscopic weighting of the panel, and they are the only items this manuscript describes as meeting the consensus standard (Table 1; Fig. 2).
Fig. 2.

Heat map of agreement (% Agree or Strongly agree) for the 17 survey statements, overall and by practice-profile stratum. Rows above the horizontal line met the prespecified consensus standard; rows below did not. Values below the 70% threshold are shown in bold with a dagger (†). Darker shading indicates higher agreement. *“Selected” denotes 1- to 2-level central or lateral recess stenosis without instability; “comparable” paraphrases the instrument wording “equivalent.” ASD, adjacent segment degeneration; LSS, lumbar spinal stenosis. Exact 95% confidence intervals for every cell are given in Tables 1 and 2.
Three features of this set deserve comment.
First, the 2 items with lowest overall agreement—C2 at 78.1% (95% CI, 69.0%–85.6%) and C9 at 76.2% (95% CI, 66.9%–84.0%)—are among the most robust once stratified, with microscopically oriented respondents endorsing them at 84.6% (95% CI, 54.6%–98.1%) and 100% (95% CI, 75.3%–100%) respectively. Agreement that platforms deliver comparable 1- to 2-year outcomes in selected stenosis, and that cost-effectiveness is healthsystem- determined, is if anything stronger outside the endoscopic majority. A flat overall threshold would rank these below more fragile items.
Second, C5 and C10 are substantive concessions to the Pro-Microscopic position, holding across all strata. That 90.5% (95% CI, 83.2%–95.3%) of an endoscopy-enriched panel affirms a steeper learning curve requiring structured training indicates this is not disputed as fact but as policy consequence—the burden is accepted, the inference that it should constrain adoption rejected. Near-universal agreement on C10 places the locus of safety in training and case selection, not technology: common ground between both advocacy positions.
Third, and most consequentially for interpreting this survey, C3 (reduced length of hospital stay) fails the consensus standard despite 91.4% overall agreement—100% balanced-practice, 94.6% endoscopic, yet only 61.5% (8 of 13; 95% CI, 31.6%–86.1%) microscopically oriented. C3 is therefore reported in Section 9.4. This illustrates why overall threshold alone is insufficient: an item can command near-unanimity in the pool while failing to persuade the stratum whose practice it most directly challenges.
4. Statements Showing Mixed Opinion or Persistent Divergence
Ten statements did not meet the prespecified consensus standard and are reported in Table 2 and Fig. 2 with all positions preserved; C6, on whether outcomes differ by endoscopic approach, is examined further in Section 9.5.
1) Why the panel rejects the inadequate decompression critique
The clash between D4 and the radiological literature is sharp enough to warrant dissection rather than mere reporting. Postoperative cauda equina clumping was documented in 40.8% of patients after endoscopic decompression for severe stenosis and correlated with worse intermediate-term pain and disability [35], yet fewer than one respondent in 5 accepts that inadequate central decompression is a meaningful risk. Four explanations are available, and they are not mutually exclusive.
The first is observability. Cauda equina clumping is a finding on postoperative magnetic resonance imaging (MRI), and postoperative MRI is not routinely obtained after uneventful decompression. A surgeon whose patients improve clinically has no occasion to acquire the image in which the finding would appear. The evidence for the critique is therefore largely invisible in ordinary practice, and expert perception here reflects what is seen rather than what occurs.
The second is attribution. Surgeons judge decompression adequacy intraoperatively, by direct endoscopic visualization of a decompressed and pulsatile dura at magnification that exceeds the microscope’s in a deep corridor. That immediate visual confirmation is a more salient evidence source than a delayed radiological surrogate, and it systematically favors confidence. Where a patient does fail, the failure presents months later and is readily attributed to recurrent stenosis, adjacent-segment disease, or non-operative pain generators rather than to the index decompression.
The third is construct validity. It is not established that clumping represents inadequate decompression rather than a residual finding of chronically compressed and redundant nerve roots that resolves slowly after adequate decompression. The correlation with worse intermediate-term outcome is compatible with both readings, and with a third in which clumping is principally a marker of preoperative stenosis severity rather than a consequence of the operation. The panel may be rejecting a causal claim that the data do not in fact establish.
The fourth is platform mismatch, and it connects directly to Section 9.5. The statement as worded concerned uniportal decompression, whereas the clumping data derive from a biportal cohort. Respondents may have rejected a proposition about a platform other than the one from which the evidence comes. This possibility cannot be excluded from the present data and is a limitation of the instrument.
The reconciliation is that expert perception and radiological data are answering different questions on different timescales with different instruments, and neither is straightforwardly wrong. What the divergence identifies is a measurable gap: no comparative study has paired routine postoperative imaging with patient-reported outcomes across both platforms in severe central stenosis. Until one does, the underdecompression critique remains a hypothesis that surgeons are structurally unlikely to encounter in practice and that the literature is not yet designed to confirm or refute.
2) The replacement standard: why a strict bar and a permissive majority view coexist
Section 1 characterizes the replacement standard—that endoscopy must exceed microscopic efficacy while delivering equal or lower complications—as asymmetric. The survey complicates this characterization. Asked directly whether this is the correct standard, 75 respondents (71.4%) rated it 4 or 5 on a 5-point scale (median 4). Endorsement was highest in the microscopic stratum (84.6%; 95% CI, 54.6%–98.1%), substantial in the endoscopic stratum (74.3%; 95% CI, 62.8%–83.8%), and lowest in the balanced stratum at 50.0% (95% CI, 26.0%–74.0%). The standard this manuscript calls asymmetric is endorsed by most surgeons it favors and those it disadvantages alike.
Two observations follow.
First, the panel applies a familiar principle of clinical conservatism rather than technique-specific prejudice. Where an established platform carries a deep evidence base and a challenger does not, burden of proof sits with the challenger; asymmetry in standard is the intended consequence of asymmetry in evidence. Surgeons accept this routinely for new implants and devices. The standard is not unfair—it is the ordinary price of displacing an incumbent, and Section 1’s framing understates its legitimacy.
Second, and more important, endorsing the strict standard barely predicts the E2 response. Among 75 endorsing it, 57.3% judged endoscopy has met the bar across most indications; among 30 not endorsing it, 46.7% did. The strict standard is therefore not the locus of disagreement. Respondents showed broad agreement on what replacement requires, though this varied by practice profile: 71.4% overall endorsed the strict standard (median 4 on 5-point scale), with 84.6% in the microscopic stratum, 74.3% in the endoscopic stratum, and 50.0% in the balanced stratum. They disagree whether current evidence satisfies it—relocating debate from threshold philosophy to evidence appraisal, and explaining how a panel can hold demanding standard and permissive verdict simultaneously without inconsistency.
Response distribution (E2): 57 (54.3%) “yes, across most indications,” 23 (21.9%) “yes, but only for specific indications,” 21 (20.0%) “not yet, but likely within 5–10 years,” and 4 (3.8%) “not yet, and unlikely in the foreseeable future.” Qualified and unqualified affirmative responses together (76.2%) closely approximate, but derive from a different instrument than, 75.2% Likert agreement on D5; the one-respondent difference reflects separate question formats, not data discrepancy. It tracks practice profile closely: 86.5% endoscopic stratum versus 38.5% (95% CI, 13.9%–68.4%) microscopic stratum (D5).
Free-text responses illustrate divergence. A European surgeon with more than 20 years in balanced practice observed that endoscopy is elegant for advanced surgeons, yet microscopy remains relevant “especially in large institutions where numerous young colleagues have to learn a new surgical technique and become independent quickly,” adding the goal “should be to get a good result and have happy patients, not to enforce one particular technique because it is en vogue.” An Asia-Pacific surgeon in exclusively endoscopic practice reported the opposite conclusion from more than 500 personal cases, judging that the endoscope can replace microscopic decompression with fewer infections and dural tears. A Latin American surgeon in exclusively endoscopic practice rejected the standard’s framing itself, arguing that a technique offering equal efficacy with fewer complications should qualify for replacement without demonstrating superior efficacy. The same respondent group supplied the survey’s most self-critical observation: a Latin American endoscopic surgeon warned that patient demand may generate “less-than-ideal indications” for decompression in patients better served by fusion.
Finally, respondents were asked what single piece of evidence would most change their answer. Despite the majority judgment that the replacement bar has been met, dominant responses were long-term comparative outcome data, multicenter rather than single-center studies, randomized trials with revision endpoints, and cost-effectiveness analysis. Several respondents answering “yes, across most indications” nominated a large randomized trial demonstrating inferior function or higher reoperation rates with endoscopy—evidence not yet existing in either direction. The panel’s confidence therefore rests substantially on accumulated personal experience rather than on the comparative evidence base, a distinction Section 10 takes as starting point.
5. Platform Heterogeneity: Is “Endoscopy” One Comparator or Three?
Sections 2–8 argue “endoscopy” against “microscopy”; the survey asked respondents to render judgments on the same binary. Both are simplifications; the survey supplies evidence that they are.
Asked whether endoscopic decompression outcomes differ meaningfully by approach—uniportal interlaminar, unilateral biportal, or uniportal foraminal—respondents divided evenly: 36.2% agreed, 30.5% disagreed, 33.3% neutral. This is the sole item without a clear majority in either direction, failing the consensus standard in every stratum. Unfamiliarity does not explain it: 70 (66.7%) practice more than one endoscopic platform, and among biportal surgeons agreement was lower (28.8%) than among nonbiportal (43.4%). Surgeons using these techniques daily, with direct comparative experience, do not agree whether they constitute one platform or three.
The methodological consequence is substantial. A continuous-irrigation biportal construct with full bimanual instrument freedom and a single-channel uniportal system with a millimeter-scale working channel differ in visualization medium, instrument degrees of freedom, osseous working capacity, irrigation dynamics, and learning trajectory. Aggregation dilutes technical arguments in both directions: the Pro-Endoscopic case for bimanual osseous work in severe stenosis rests principally on biportal capability; the Pro-Microscopic case concerning constrained corridors and single-channel instrument conflict applies most forcefully to uniportal systems. Several domain-level arguments in Sections 3–6 are accordingly stronger against one endoscopic platform than the other; the reader should hold the specific platform in view rather than reading them as claims about endoscopy generically.
The same aggregation affects the evidence base. Randomized trials of full-endoscopic interlaminar decompression, biportal-versus-microscopic trials, and propensity-matched database analyses recruit from different technical populations; pooling them into a single “endoscopic” arm—as most meta-analyses do—imports the same ambiguity into summary estimates both advocacy positions rely upon. The platform mismatch in Section 9.4.1, where a statement about uniportal decompression was answered against biportal-derived evidence, is a concrete instance of this problem operating within the survey.
We report this as a structural limitation rather than resolving it, because the requisite data do not exist: no adequately powered trial has compared uniportal and biportal decompression against each other and against microscopic decompression in a 3-arm design. Until such comparison exists, “endoscopy versus microscopy” should be understood as shorthand for a comparison whose experimental arm is not internally homogeneous; future comparative work should specify and stratify by endoscopic platform as routine, not treat platform as an incidental descriptor.
6. Methodological Notes and Limitations
This survey was a single-round structured international expert survey, not a formal Delphi or iterative consensus process. There were no iterative rounds and no controlled feedback of group responses between rounds. The term “consensus” is applied only to the 7 statements meeting the prespecified conjunctive rule in Section 9.3; the distribution labels in Section 9.2 are descriptive summaries of respondent opinion and are not evidence of comparative effectiveness. Aggregate opinion cannot substitute for comparative data, and where the survey and the literature diverge—most conspicuously on the underdecompression question—the divergence is dissected in Section 9.4.1 rather than reconciled.
1) Sampling frame
The most important limitation is the recruitment channel and the resulting endoscopic skew. Respondents were reached through endoscopic and minimally invasive spine surgery networks, producing a panel in which 74 of 105 respondents (70.5%) practice predominantly or almost exclusively endoscopically and only 13 (12.4%) predominantly or almost exclusively microscopically. This is a sample of surgeons with endoscopic expertise, not a representative sample of spine surgeons, and it should be read as such. Practice profile was a strong modifier of most responses examined, though not all: for example, C10 (surgeon experience and case selection influence complication rate more than platform) showed near-uniform agreement across strata (92.3% microscopic, 94.4% balanced, 93.2% endoscopic), and cost judgments tracked reimbursement environment closely (Section 9.2). The conjunctive consensus standard was adopted specifically to prevent this imbalance from manufacturing apparent agreement, and its effect is visible in the results: it removes C3 despite 91.4% overall agreement and admits C2 and C9 despite lower overall figures. The direction of the residual bias is nonetheless knowable and consistent—it inflates endoscopy-favoring distributions across all 7 domains—so the pro-microscopic findings reported here should be read as conservative estimates obtained despite rather than because of the sampling frame.
2) Subgroup fragility
The conjunctive rule depends on a microscopic stratum of only 13 respondents, in which each individual represents 7.7 percentage points. Four consensus items (C1, C2, C4, C5) sit at 84.6% in that stratum, corresponding to 11 of 13, and would survive one further dissenting response but not two; C9 in the balanced stratum sits at 72.2%, corresponding to 13 of 18, and would fail on a single changed response. The classification of individual items close to the threshold is therefore not robust, even though the overall pattern—endoscopic and balanced strata agreeing substantially more than the microscopic stratum on every directional claim—is stable and does not depend on any single respondent. Items should be read as occupying a gradient of agreement rather than 2 discrete categories.
3) Regional distribution and its clinical implications
Asia-Pacific and Latin America together contributed 68 of 105 responses (64.8%), against 23 from Europe (21.9%), 9 from the Middle East and Africa (8.6%), and 5 from North America (4.8%). This distribution has 2 distinct consequences that should not be conflated.
The first consequence is economic. Reimbursement environment patterned strongly by region: 22 of 28 Latin American respondents (78.6%) practice in predominantly fee-for-service or private systems, none in single-payer; 18 of 40 Asia-Pacific (45.0%) and 8 of 23 European (34.8%) in single-payer or public systems. North America, where restrictive coverage determinations for endoscopic decompression have been among the most consequential adoption barriers, contributed 5 responses. Cost judgments tracked reimbursement environment closely (Section 9.2); health systems where the economic case for endoscopy is hardest to make are least represented, and cost findings should be treated as the least generalizable.
The second consequence is clinical. Surgical populations differ across regions in body habitus, age and comorbidity profile, prevalence of heavily ossified pathology, symptom duration before referral, and surgical thresholds—all bearing directly on relative platform performance. Respondent judgments are formed against actual case mix; a panel drawn predominantly from 2 regions reports predominantly on 2 regions’ case mixes. Patient-level data were not collected, so effect magnitude cannot be estimated; multicenter trials proposed in Section 10 should report population characteristics in sufficient detail for readers to judge transportability rather than assume it.
Further limitations. Response rate cannot be calculated: distribution through open professional networks without a closed denominator precludes quantifying nonresponse bias. Free-text responses were reviewed thematically by co-first authors without formal qualitative coding or independent double-coding; quoted statements were selected to illustrate position range rather than by systematic sampling. Because identification preferences were separated from the analytic dataset (see Materials and Methods), responses cannot be attributed beyond region, experience, and practice profile. Finally, as set out in Section 9.5, the instrument treated “endoscopic decompression” as a single comparator in most items, limiting resolution of every reported judgment.
7. Overall Interpretation
Coexistence, not replacement. Endoscopic decompression has demonstrated comparable outcomes for selected pathologies and incremental perioperative advantages in specific domains. Durable long-term superiority across the full decompressive spectrum remains unestablished; the requisite evidence—subtype-stratified, platform-specific, multicenter, extending beyond 5 years—does not yet exist. The surveyed panel reached a more permissive conclusion, with the majority judging the replacement bar already met; this is best understood as expert forecast grounded in accumulated operative experience, not summary of comparative evidence, and is strongly conditioned by endoscopic sample weighting. Notably, the 7 statements surviving stratification concern perioperative advantage, training burden, comparable outcomes in selected stenosis, and standardized reporting need—not replacement, which fails the consensus standard clearly in both microscopic and balanced strata. The microscope remains the pragmatic default for complex multilevel disease, revision with dense scarring, and concurrent fusion. Platform selection should be pathology-matched, platform-specific, and patient-specific.
SECTION 10. FUTURE DIRECTIONS AND NEEDED RANDOMIZED CONTROLLED TRIALS
Future directions in ESS are typically framed around technological adjuncts—augmented reality, navigation, robotics, artificial intelligence—as levers to alter the balance against the microscope. Han et al. [63] note augmented reality remains limited to feasibility studies without an adequately powered multicenter trial. Most enabling technology studies report accuracy, radiation exposure, and ergonomics rather than patient-reported outcomes, complication rates, or long-term durability. A second limitation is the near absence of multicenter head-to-head RCTs comparing ESS with microsurgery for pathologies where technical advantages are theoretically greatest: foraminal stenosis, multilevel central stenosis in the elderly, and revision after prior microsurgical decompression. The percutaneous transforaminal endoscopic discectomy (PTED) trial [21,64] and UBE-versus-microscopy trial [25] remain principal level I comparative evidence, both limited to single-level lumbar disc herniation.
This study proposes that the most important future directions are methodological rather than technological. Methodological gaps identified in parallel discectomy literature—short follow-up, absent subtype stratification, lack of standardized core outcomes, underreported cost-effectiveness data—apply equally to decompression evidence base [8]. Four priorities: multicenter pragmatic RCTs in foraminal stenosis with structural and functional endpoints beyond 5 years; RCTs comparing UBE-assisted decompression with microscopic ULBD in elderly multilevel stenosis with prespecified subtype stratification; head-to-head trials of endoscopic versus microscopic revision after prior microdiscectomy; registry-based long-term studies with standardized core outcome sets and embedded cost-effectiveness analyses to settle questions of ASD. The PTED trial [21,64] provides a methodological template (formal noninferiority RCT design with a prespecified margin, 613 patients, parallel cost-effectiveness analysis); the international classification of endoscopic spine procedures [60] provides a standardization framework for multicenter trial design. Telang et al. [1] argue pragmatic registry data should substitute for RCTs given rapid technological change; this has merit for technology-comparison questions but does not address underlying decompression-approach questions.
The survey adds empirical warrant for this methodological emphasis. Asked what single piece of evidence would most change their position, respondents overwhelmingly nominated long-term comparative outcome data, multicenter rather than single-center designs, randomized trials with revision endpoints, and formal cost-effectiveness analysis, including respondents who had already judged the replacement bar met. A panel considering question settled while simultaneously identifying evidence that would unsettle it describes a field operating ahead of its evidence base.
CONCLUSION
ESS is not yet positioned to replace the operating microscope across the full lumbar decompression spectrum, though the distance between platforms is now smaller than at any previous point. Endoscopy has demonstrated comparable outcomes for selected pathologies and incremental perioperative advantages in specific domains—most clearly complication profile, patient selection for focal and single-level disease, and early functional recovery—but not durable long-term superiority. Subtype-stratified multicenter data extending beyond 5 years, requisite to settle this question, do not yet exist for either platform.
The surveyed panel reached a more permissive judgment, with the majority judging the replacement threshold already met; this does not survive stratification by practice profile and is best read as expert forecast conditioned by endoscopic sample weighting—expressed by respondents who nominated long-term randomized data as evidence that would change their minds. The gap between what evidence has established and what experienced surgeons already believe is itself among this study’s more informative findings.
The appropriate model is coexistence, echoing recent discectomy consensus: platform selection matched to pathology, patient phenotype, and surgeon expertise, supported by structured training and standardized long-term reporting. One qualification conditions every conclusion: uniportal and biportal decompression are not interchangeable, and “microscopic decompression” encompasses conventional laminectomy, microsurgical laminotomy, and tubular retractor systems with differing soft-tissue disruption profiles. The question that will matter over the next decade may not be whether endoscopy replaces the microscope, but which endoscopy, for which patient, in which health system, against which microscopic comparator.
Footnotes
Conflict of Interest
The authors have nothing to disclose.
Funding/Support
This study received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Acknowledgments
The authors thank all survey respondents.
Author Contribution
Conceptualization: LMQ, SKC, SMP, YHL, BS; Methodology (debate framework and survey design): YHL, BS, LMQ; Investigation (advocacy position drafting and survey distribution): YHL, BS, AB, AF, BLC, CS, DR, DCA, DA, DD, DCL, FW, JSK, JRdS, MS, MMHY, TJ, WT, WL, LMQ, SKC, SMP; Data curation and formal analysis: YHL, BS; Writing – original draft: YHL, BS; Writing – review & editing: YHL, BS, AB, AF, BLC, CS, DR, DCA, DA, DD, DCL, FW, JSK, JRdS, MS, MMHY, TJ, WT, WL, LMQ, SKC, SMP; Supervision: LMQ, SKC, SMP, JSK.
Supplementary Materials
Supplementary Materials 1–3 are available at https://doi.org/10.14245/ns.26521618.0809.
Blank survey instrument
Consensus-Based Checklist for Reporting of Survey Studies (CROSS)
REFERENCES
- 1.Telang S, Telang SS, Palmer R, et al. Evolving role of lumbar decompression: a narrative review. Int J Spine Surg. 2025;19:117–28. doi: 10.14444/8702. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Yasargil MG. In: Lumbar disc adult hydrocephalus. Advances in neurosurgery. vol 4. Wüllenweber R, Brock M, Hamer J, et al., editors. Berlin: Springer; 1977. Microsurgical operation of herniated lumbar disc; p. 81. [Google Scholar]
- 3.Caspar W. In: Lumbar disc adult hydrocephalus. Advances in neurosurgery, vol 4. Wüllenweber R, Brock M, Hamer J, et al., editors. Berlin: Springer; 1977. A new surgical procedure for lumbar disc herniation causing less tissue damage through a microsurgical approach; pp. 74–80. [Google Scholar]
- 4.Kambin P, Sampson S. Posterolateral percutaneous suction-excision of herniated lumbar intervertebral discs. Report of interim results. Clin Orthop Relat Res. 1986;(207):37–43. [PubMed] [Google Scholar]
- 5.Telfeian AE, Veeravagu A, Oyelese AA, et al. A brief history of endoscopic spine surgery. Neurosurg Focus. 2016;40:E2. doi: 10.3171/2015.11.FOCUS15429. [DOI] [PubMed] [Google Scholar]
- 6.Chen KT, Kim JS, Huang AP, et al. Current indications for spinal endoscopic surgery and potential for future expansion. Neurospine. 2023;20:33–42. doi: 10.14245/ns.2346190.095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Chin BZ, Yong JH, Wang E, et al. Full-endoscopic versus microscopic spinal decompression for lumbar spinal stenosis: a systematic review & meta-analysis. Spine J. 2024;24:1022–33. doi: 10.1016/j.spinee.2023.12.009. [DOI] [PubMed] [Google Scholar]
- 8.Santipas B, Kim JS, Mekariya K, et al. Beyond the microscope: is endoscopic discectomy the next gold standard for lumbar disc herniation? Neurospine. 2026;23:61–79. doi: 10.14245/ns.2551450.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lewandrowski KU, Telfeian AE, Hellinger S, et al. Difficulties, challenges, and the learning curve of avoiding complications in lumbar endoscopic spine surgery. Int J Spine Surg. 2021;15(suppl 3):S21–37. doi: 10.14444/8161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Schoenberg NC, Barker AF, Bernardo J, et al. A comparative of pulmonary and critical care medicine guideline development methodologies. Am J Respir Crit Care Med. 2017;196:621–7. doi: 10.1164/rccm.201705-0926OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Sharma A, Minh Duc NT, Luu Lam Thang T, et al. A consensus-based checklist for reporting of survey studies (CROSS) J Gen Intern Med. 2021;36:3179–87. doi: 10.1007/s11606-021-06737-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Heo DH, Kim HS, Whang YH, et al. History of endoscopic spine surgery: where did it all begin? Development of indications and techniques. Spine J. 2026;26:467–78. doi: 10.1016/j.spinee.2025.07.031. [DOI] [PubMed] [Google Scholar]
- 13.Heo DH, Son SK, Eum JH, et al. Fully endoscopic lumbar interbody fusion using a percutaneous unilateral biportal endoscopic technique: technical note and preliminary clinical results. Neurosurg Focus. 2017;43:E8. doi: 10.3171/2017.5.FOCUS17146. [DOI] [PubMed] [Google Scholar]
- 14.Jitpakdee K, Liu Y, Heo DH, et al. Minimally invasive endoscopy in spine surgery: where are we now? Eur Spine J. 2023;32:2755–68. doi: 10.1007/s00586-023-07622-7. [DOI] [PubMed] [Google Scholar]
- 15.Park SM, Kim HJ, Kim GU, et al. Learning curve for lumbar decompressive laminectomy in biportal endoscopic spinal surgery using the cumulative summation test for learning curve. World Neurosurg. 2019;122:e1007–13. doi: 10.1016/j.wneu.2018.10.197. [DOI] [PubMed] [Google Scholar]
- 16.Peng J, Lin R, Fang D, et al. Learning curve insights in unilateral biportal endoscopic (UBE) spinal procedures: proficiency cutoffs and the impact on efficiency and complications. Eur Spine J. 2025;34:954–73. doi: 10.1007/s00586-024-08632-9. [DOI] [PubMed] [Google Scholar]
- 17.Chan JP, Olson T, Gabriel B, et al. What is the learning curve for endoscopic spine surgery? A comprehensive systematic review. Spine J. 2026;26:438–49. doi: 10.1016/j.spinee.2025.01.004. [DOI] [PubMed] [Google Scholar]
- 18.Koh CH, Booker J, Choi D, et al. Learning curve of endoscopic lumbar discectomy - a systematic review and metaanalysis of individual participant and aggregated data. Global Spine J. 2025;15:1435–44. doi: 10.1177/21925682241289901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Park SC, Park SM, Chung HJ, et al. Learning curve for full-endoscopic lumbar decompression via interlaminar approach using the learning curve cumulative summation analysis. J Orthop Surg Res. 2025;20:297. doi: 10.1186/s13018-025-05699-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Scherman DB, Madani D, Gambhir S, et al. Predictors of clinical failure after endoscopic lumbar spine surgery during the initial learning curve. World Neurosurg. 2024;182:e506–16. doi: 10.1016/j.wneu.2023.11.137. [DOI] [PubMed] [Google Scholar]
- 21.Gadjradj PS, Rubinstein SM, Peul WC, et al. Full endoscopic versus open discectomy for sciatica: randomised controlled non-inferiority trial. BMJ. 2022;376:e065846. doi: 10.1136/bmj-2021-065846. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Park DK, Weng C, Zakko P, et al. Unilateral biportal endoscopy for lumbar spinal stenosis and lumbar disc herniation. JBJS Essent Surg Tech. 2023;13:e22.00020. doi: 10.2106/JBJS.ST.22.00020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Sarikonda A, Sivaganesan A, Qureshi S, et al. Advanced visualization in minimally invasive spine surgery: the ergonomics, economics, and evolution of camera-based tubes and retractors. Int J Spine Surg. 2024;18(S1):S64–70. doi: 10.14444/8643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Bartlett AM, Robertson FC, Shaker E, et al. Disruptive technologies in spine surgery: current trends, outcomes, and ethical implications. J Neurosurg Spine. 2026;44:756–68. doi: 10.3171/2025.10.SPINE25999. [DOI] [PubMed] [Google Scholar]
- 25.Park SM, Lee HJ, Park HJ, et al. Biportal endoscopic versus microscopic discectomy for lumbar herniated disc: a randomized controlled trial. Spine J. 2023;23:18–26. doi: 10.1016/j.spinee.2022.09.003. [DOI] [PubMed] [Google Scholar]
- 26.Kim JH, Kim YJ, Ryu KS, et al. Comparison of the clinical and radiological outcomes of full-endoscopic laminotomy and conventional subtotal laminectomy for lumbar spinal stenosis: a randomized controlled trial. Global Spine J. 2024;14:1760–70. doi: 10.1177/21925682231155846. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Park J, Ahn DK, Choi DJ, et al. Treatment concept and technical considerations of biportal endoscopic spine surgery for lumbar spinal stenosis. Asian Spine J. 2024;18:301–23. doi: 10.31616/asj.2023.0409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Wang R, Zeng W, Hong AT, et al. Short-term outcomes and 2-year reoperations following endoscopic versus microdiscectomy for lumbar disc herniation: a propensity-matched analysis. World Neurosurg. 2026;206:124794. doi: 10.1016/j.wneu.2026.124794. [DOI] [PubMed] [Google Scholar]
- 29.Wu Y, Shen R, Li S, et al. Fusion surgery for lumbar spondylolisthesis: a systematic review with network meta-analysis of randomized controlled trials. World Neurosurg. 2024;185:327–37.e1. doi: 10.1016/j.wneu.2024.02.051. [DOI] [PubMed] [Google Scholar]
- 30.Liawrungrueang W, Cholamjiak W, Sarasombath P, et al. Endoscopic spine surgery for obesity-related surgical challenges: a systematic review and meta-analysis of current evidence. Asian Spine J. 2025;19:292–310. doi: 10.31616/asj.2024.0376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Yagi K, Kishima K, Tezuka F, et al. Advantages of revision transforaminal full-endoscopic spine surgery in patients who have previously undergone posterior spine surgery. J Neurol Surg A Cent Eur Neurosurg. 2023;84:528–35. doi: 10.1055/a-1877-0594. [DOI] [PubMed] [Google Scholar]
- 32.Pür B, Yılar S, Dağ İ, et al. Frailty-modulated outcomes after microscopic versus unilateral biportal endoscopic decompression for degenerative lumbar spinal stenosis without instability. Spine (Phila Pa 1976) doi: 10.1097/BRS.0000000000005696. 2026 Mar 20. doi: 10.1097/BRS.0000000000005696. [Epub] [DOI] [PubMed] [Google Scholar]
- 33.Ross N, Aleman C, Dhenin A, et al. Tubular versus unilateral biportal endoscopy: MRI analysis after unilateral laminectomy for bilateral decompression in lumbar spinal stenosis. Eur Spine J. 2025;34:2972–80. doi: 10.1007/s00586-025-08953-3. [DOI] [PubMed] [Google Scholar]
- 34.Soares RO, Astur N, Rabello de Oliveira L, et al. Qualitative evaluation of paraspinal musculature after minimally invasive lumbar decompression: a prospective study. Int J Spine Surg. 2024;18:448–54. doi: 10.14444/8631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Lee HR, Lee SY, Seong H, et al. Impact of postoperative cauda equina clumping on recovery after biportal endoscopic decompression for severe lumbar stenosis. Eur Spine J. 2025;34:404–14. doi: 10.1007/s00586-024-08563-5. [DOI] [PubMed] [Google Scholar]
- 36.Komp M, Hahn P, Oezdemir S, et al. Bilateral spinal decompression of lumbar central stenosis with the full-endoscopic interlaminar versus microsurgical laminotomy technique: a prospective, randomized, controlled study. Pain Physician. 2015;18:61–70. [PubMed] [Google Scholar]
- 37.Yang Z, Wang H, Li W, et al. Comparative effects and safety of full-endoscopic versus microscopic spinal decompression for lumbar spinal stenosis: a meta-analysis and statistical power analysis of 6 randomized controlled trials. Neurospine. 2022;19:996–1005. doi: 10.14245/ns.2244600.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Park SM, Park J, Jang HS, et al. Biportal endoscopic versus microscopic lumbar decompressive laminectomy in patients with spinal stenosis: a randomized controlled trial. Spine J. 2020;20:156–65. doi: 10.1016/j.spinee.2019.09.015. [DOI] [PubMed] [Google Scholar]
- 39.Pranata R, Lim MA, Vania R, et al. Biportal endoscopic spinal surgery versus microscopic decompression for lumbar spinal stenosis: a systematic review and meta-analysis. World Neurosurg. 2020;138:e450–8. doi: 10.1016/j.wneu.2020.02.151. [DOI] [PubMed] [Google Scholar]
- 40.Min WK, Kim JE, Choi DJ, et al. Clinical and radiological outcomes between biportal endoscopic decompression and microscopic decompression in lumbar spinal stenosis. J Orthop Sci. 2020;25:371–8. doi: 10.1016/j.jos.2019.05.022. [DOI] [PubMed] [Google Scholar]
- 41.Heo DH, Lee DC, Park CK, et al. Comparative analysis of three types of minimally invasive decompressive surgery for lumbar central stenosis: biportal endoscopy, uniportal endoscopy, and microsurgery. Neurosurg Focus. 2019;46:E9. doi: 10.3171/2019.2.FOCUS197. [DOI] [PubMed] [Google Scholar]
- 42.Komp M, Hahn P, Merk H, et al. Bilateral operation of lumbar degenerative central spinal stenosis in full-endoscopic interlaminar technique with unilateral approach: prospective 2-year results of 74 patients. J Spinal Disord Tech. 2011;24:281–7. doi: 10.1097/BSD.0b013e3181f9f55e. [DOI] [PubMed] [Google Scholar]
- 43.Park SM, Song KS, Ham DW, et al. Safety profile of biportal endoscopic spine surgery compared to conventional microscopic approach: a pooled analysis of 2 randomized controlled trials. Neurospine. 2024;21:1190–8. doi: 10.14245/ns.2448718.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Yang L, Yu T, Jiao J, et al. Comprehensive analysis of UBE-related complications: prevention and management strategies from 4685 patients. Med Sci Monit. 2024;30:e944018. doi: 10.12659/MSM.944018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Ju CI, Lee SM. Complications and management of endoscopic spinal surgery. Neurospine. 2023;20:56–77. doi: 10.14245/ns.2346226.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Yang CC, Chen CM, Lin MH, et al. Complications of full-endoscopic lumbar discectomy versus open lumbar microdiscectomy: a systematic review and meta-analysis. World Neurosurg. 2022;168:333–48. doi: 10.1016/j.wneu.2022.06.023. [DOI] [PubMed] [Google Scholar]
- 47.Chen L, Guan B, Anderson DB, et al. Surgical interventions for degenerative lumbar spinal stenosis: a systematic review with network meta-analysis. BMC Med. 2024;22:430. doi: 10.1186/s12916-024-03653-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Ruetten S, Komp M, Merk H, et al. Surgical treatment for lumbar lateral recess stenosis with the full-endoscopic interlaminar approach versus conventional microsurgical technique: a prospective, randomized, controlled study. J Neurosurg Spine. 2009;10:476–85. doi: 10.3171/2008.7.17634. [DOI] [PubMed] [Google Scholar]
- 49.Mahan MA, Prasse T, Kim RB, et al. Full-endoscopic spine surgery diminishes surgical site infections - a propensity score-matched analysis. Spine J. 2023;23:695–702. doi: 10.1016/j.spinee.2023.01.009. [DOI] [PubMed] [Google Scholar]
- 50.Lee CH, Choi M, Ryu DS, et al. Efficacy and safety of full-endoscopic decompression via interlaminar approach for central or lateral recess spinal stenosis of the lumbar spine: a meta-analysis. Spine (Phila Pa 1976) 2018;43:1756–64. doi: 10.1097/BRS.0000000000002708. [DOI] [PubMed] [Google Scholar]
- 51.Cheung PWH, Wong CKH, Lau ST, et al. Cost analysis comparison between conventional microsurgical decompression and full-endoscopic interlaminar decompression for lumbar spinal stenosis surgery. J Spine Surg. 2020;6:721–8. doi: 10.21037/jss-20-552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Choi KC, Shim HK, Kim JS, et al. Cost-effectiveness of microdiscectomy versus endoscopic discectomy for lumbar disc herniation. Spine J. 2019;19:1162–9. doi: 10.1016/j.spinee.2019.02.003. [DOI] [PubMed] [Google Scholar]
- 53.Boden LM, Boden SH, Muhammad N, et al. Complications and cost in open versus endoscopic lumbar decompression: a database study. Clin Spine Surg. 2025;38:E383–7. doi: 10.1097/BSD.0000000000001745. [DOI] [PubMed] [Google Scholar]
- 54.Findlay MC, Hamrick FA, Kim RB, et al. Hospital cost differences between open and endoscopic lumbar spine decompression surgery. J Neurosurg Spine. 2023;40:77–83. doi: 10.3171/2023.8.SPINE23439. [DOI] [PubMed] [Google Scholar]
- 55.Guo J, Lv C, Bai T, et al. Comparative study of percutaneous endoscopic lumbar decompression and traditional revision surgery in the treatment of symptomatic adjacent segment degeneration. BMC Surg. 2024;24:177. doi: 10.1186/s12893-024-02470-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Leyendecker J, Mahan M, Findlay MC, et al. Full-endoscopic spinal decompression or discectomy show benefits regarding 30-day readmission rates when compared to other spine surgery techniques: a propensity score matched analysis. Spine J. 2025;25:996–1005. doi: 10.1016/j.spinee.2024.11.007. [DOI] [PubMed] [Google Scholar]
- 57.Costa F, Alves OL, Anania CD, et al. Decompressive surgery for lumbar spinal stenosis: WFNS Spine Committee recommendations. World Neurosurg X. 2020;7:100076. doi: 10.1016/j.wnsx.2020.100076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Costa F, Oertel J, Zileli M, et al. Role of surgery in primary lumbar disk herniation: WFNS spine committee recommendations. World Neurosurg X. 2024;22:100276. doi: 10.1016/j.wnsx.2024.100276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Al Barajraji M, Barrit S, Boukind A, et al. Spine endoscopic surgery establishment for disc disease (Neurocore-SENSED): an open and decentralized consensus. Brain Spine. 2025;5:105604. doi: 10.1016/j.bas.2025.105604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Farshad M, Laux CJ, Wanivenhaus F, et al. Classification of endoscopic spine procedures. N Am Spine Soc J. 2025;22:100603. doi: 10.1016/j.xnsj.2025.100603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Lewandrowski KU, Yeung A, Lorio MP, et al. Personalized interventional surgery of the lumbar spine: a perspective on minimally invasive and neuroendoscopic decompression for spinal stenosis. J Pers Med. 2023;13:710. doi: 10.3390/jpm13050710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Fornari M, Robertson SC, Pereira P, et al. Conservative treatment and percutaneous pain relief techniques in patients with lumbar spinal stenosis: WFNS Spine Committee recommendations. World Neurosurg X. 2020;7:100079. doi: 10.1016/j.wnsx.2020.100079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Han F, Xu F, Yang Y, et al. Augmented reality in non-instrumentation minimally invasive spine surgery: a narrative review and future perspectives. J Spine Surg. 2026;12:21. doi: 10.21037/jss-2025-aw-190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Gadjradj PS, Broulikova HM, van Dongen JM, et al. Cost-effectiveness of full endoscopic versus open discectomy for sciatica. Br J Sports Med. 2022;56:1018–25. doi: 10.1136/bjsports-2021-104808. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Blank survey instrument
Consensus-Based Checklist for Reporting of Survey Studies (CROSS)
